Profiel
David Balyeat has founded a company called AJNA BioSciences PBC in 2021 and currently holds the title of Vice President-Innovation & Operations.
Actieve functies van David Balyeat
Bedrijven | Functie | Begin |
---|---|---|
Ajna Biosciences Pbc
Ajna Biosciences Pbc Pharmaceuticals: OtherHealth Technology AJNA BioSciences PBC is a botanical drug development company that focuses on natural pharmaceuticals to address mental health and neurological disorders. The company is based in Littleton, CO, and was founded by David Balyeat and Joel Stanley. The company's strategy involves selecting plant and fungi species with a well-established history of therapeutic use to streamline drug discovery and mitigate late-stage clinical trial risk. AJNA's unique platform combines specialized laboratory infrastructure and clinical and regulatory expertise for rapid development of investigational new drugs. The company's commercialization strategy is designed for co-development partnerships, IP licensing, and vertically integrated drug products in a broad range of botanical species and clinical indications. AJNA is a public benefit corporation that maximizes profitability and sustainability for both people and the planet. Joel Stanley has been the CEO since incorporation. | Oprichter | 01-04-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Ajna Biosciences Pbc
Ajna Biosciences Pbc Pharmaceuticals: OtherHealth Technology AJNA BioSciences PBC is a botanical drug development company that focuses on natural pharmaceuticals to address mental health and neurological disorders. The company is based in Littleton, CO, and was founded by David Balyeat and Joel Stanley. The company's strategy involves selecting plant and fungi species with a well-established history of therapeutic use to streamline drug discovery and mitigate late-stage clinical trial risk. AJNA's unique platform combines specialized laboratory infrastructure and clinical and regulatory expertise for rapid development of investigational new drugs. The company's commercialization strategy is designed for co-development partnerships, IP licensing, and vertically integrated drug products in a broad range of botanical species and clinical indications. AJNA is a public benefit corporation that maximizes profitability and sustainability for both people and the planet. Joel Stanley has been the CEO since incorporation. | Health Technology |